Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Relationship of p21WAF1/CIP1/SDI1 to cell proliferation in primary cultures of adrenocortical cells

  • 36 Accesses

  • 2 Citations


p21WAF1/CIP1/SDI1 was originally described as a protein expressed at high levels in senescent human fibroblasts. We have studied the expression of p21 in adrenocortical cells, p21 is not expressed under most circumstances in the intact adrenal gland in vivo, except when the gland is damaged. When human and bovine adrenocortical cells are isolated and placed in both short-term and long-term culture, p21 levels are much higher. These levels did not show a large increase when the cells senesce after long-term proliferation. Thus, these observations raise the question of whether the elevated p21 in primary cultures of adrenocortical cells is caused by damage or whether p21 is elevated because the cells are dividing rather than quiescent, because it has been reported that p21 levels peak in G1 and G2 in dividing cells. In the present experiments on bovine and human adrenocortical cells in primary culture, labeling techniques that correlated nuclear p21 with measures of cell proliferation (bromodeoxyuridine incorporation and nuclear Ki-67 antigen) supported the hypothesis that p21 is associated with cell division and not with damage. This is consistent with recent data showing that, when adrenocortical cells are transplanted into immunodeficient mice, p21 is associated with healthy dividing cells in the transplant, p21 is not a unique marker for senescence, and more studies are required both to clarify its role in cell biology and to determine molecular features which characterize the senescent state of cells both in vitro and in vivo.

This is a preview of subscription content, log in to check access.


  1. 1.

    Smith, JR: Inhibitors of DNA synthesis derived from senescent human diploid fibroblasts. Exp. Gerontol., 27: 409–12, 1992.

  2. 2.

    El-Deiry, WS, Tokino, T, Velculescu, VE, Levy, DB, Parsons, R, Trent, JM, Lin, D, Mercer, WE, Kinzler, KW, and Vogelstein, B: WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817–825, 1993.

  3. 3.

    Harper, JW, Elledge, SJ, Keyomarsi, K, Dynlacht, B, Tsai, L-H, Zhang, P, Dobrowolski, S, Bai, C, Connell-Crowley, L, Swindell, E, Fox, MP, and Wei, N: Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387–400, 1995.

  4. 4.

    Noda, A, Ning, Y, Venable, SF, Pereira-Smith, OM, and Smith, JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90–98, 1994.

  5. 5.

    Levine, AJ: p53, the cellular gatekeeper for growth and division. Cell, 88: 323–31, 1997.

  6. 6.

    Paulovich, AG, Toczyski, DP, and Hartwell, LH: When checkpoints fail. Cell, 88: 315–21, 1997.

  7. 7.

    Dulic, V, Stein, GH, Far, DF, and Reed, SI: Nuclear accumulation of p21Cip1 at the onset of mitosis: A role at the G2/M-phase transition. Mol. Cell. Biol., 18: 546–557, 1998.

  8. 8.

    Niculescu, AB, Chen, XB, Smeets, M, Hengst, L, Prives, C, and Reed, SI: Effects of p21Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduptication. Mot. Cell. Biol., 18: 629–643, 1998.

  9. 9.

    El-Deiry, WS, Tokino, T, Waldman, T, Oliner, JD, Velculescu, VE, Burrell, M, Hill, DE, Healy, E, Rees, JL, Hamilton, SR, Kinzler, KW, and Vogelstein, B: Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res., 55: 2910–2919, 1995.

  10. 10.

    Hornsby, PJ, Cheng, CY, Lala, DS, Maghsoudlou, SS, Raju, SG, and Yang, L: Changes in gene expression during senescence of adrenocortical cells in culture. J. Steroid Biochem. Mol. Biol., 43: 385–395, 1992.

  11. 11.

    Thomas, M, Northrup, SR, and Hornsby, PJ: Adrenocortical tissue formed by transplantation of normal clones of bovine adrenocortical cells in scid mice replaces the essential functions of the animals’ adrenal glands. Nature Med., 3: 978–983, 1997.

  12. 12.

    Hornsby, PJ, Thomas, M, Northrup, SR, Popnikolov, NP, Wang, X, Tunstead, JR, and Zheng, J: Cell transplantation: A tool to study adrenocortical cell biology, physiology, and senescence. Endocr. Res., 24: 909–918, 1998.

  13. 13.

    Yang, L, Didenko, VV, Noda, A, Bilyeu, TA, Darlington, GD, Smith, JR, and Hornsby, PJ: Increased expression of p21Sdi1 in adrenocortical cells when they are placed in culture. Exp. Cell Res., 221: 126–131, 1995.

  14. 14.

    Didenko, VV, Wang, X, Yang, L, and Hornsby, PJ: Expression of p21WAF1/CIP1/SDI1 and p53 in apoptotic cells in the adrenal cortex and induction by ischemia/reperfusion injury. J. Clin. Invest., 97: 1723–1731, 1996.

  15. 15.

    Didenko, VV, Wang, X, Yang, L, and Hornsby, PJ: p21 and apoptosis in experimental damage of the rat adrenal cortex and trauma-associated damage of the human adrenal cortex. J. Pathol. (in press), 1999.

  16. 16.

    Tunstead, JR, and Hornsby, PJ: Early events in the formation of a tissue structure from dispersed bovine adrenocortical cells following transplantation into scid mice. (submitted), 1999.

  17. 17.

    Hornsby, PJ, and McAllister, JM: Culturing steroidogenic cells, in Methods in Enzymology, Vol. 206, edited by Waterman, MR, and Johnson, EF, San Diego, Academic, 1991, pp. 371–380.

  18. 18.

    Hornsby, PJ: Culturing steroidogenic cells, in Cell and Tissue Culture: Laboratory Procedures, 17B, edited by Griffiths, JB, Doyle, A, and Newell, DG, Chichester, England, Wiley, 1994, pp. 7.1–7.9.

  19. 19.

    Yu, CC, Woods, AL, and Levison, DA: The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem. J., 24: 121–31, 1992.

  20. 20.

    Hornsby, PJ, and Yang, L: A model for phenotypic switching in adrenocortical cells senescing in culture. Mech. Ageing Dev., 58: 1–12, 1991.

  21. 21.

    Alcorta, DA, Xiong, Y, Phelps, D, Hannon, G, Beach, D, and Barrett, JC: Involvement of the cyclin-dependent kinase inhibitor p16INK4a in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742–13747, 1996.

  22. 22.

    Deng, C, Zhang, P, Harper, JW, Elledge, SJ, and Leder, P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675–684, 1995.

  23. 23.

    Nakayama, K, Ishida, N, Shirane, M, Inomata, A, Inoue, T, Shishido, N, Horii, I, Loh, DY, and Nakayama, K: Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707–20, 1996.

  24. 24.

    Zhang, PM, Liegeois, NJ, Wong, C, Finegold, M, Hou, H, Thompson, JC, Silverman, A, Harper, JW, DePinho, RA, and Elledge, SJ: Altered cell differentiation and proliferation in mice lacking p57Kip2 indicates a role in Beckwith-Wiedemann-syndrome. Nature, 387: 151–158, 1997.

Download references

Author information

Correspondence to Peter J. Hornsby.

About this article

Cite this article

Tunstead, J.R., Hornsby, P.J. Relationship of p21WAF1/CIP1/SDI1 to cell proliferation in primary cultures of adrenocortical cells. AGE 22, 39 (1999). https://doi.org/10.1007/s11357-999-0005-4

Download citation


  • Primary Culture
  • Adrenal Gland
  • Bromodeoxyuridine
  • Immunodeficient Mouse
  • Label Technique